Multitarget therapeutic strategies for Alzheimer's disease  

作　　者：Mostafa M.Ibrahim Moustafa T.Gabr 

机构地区：[1]Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University [2]Department of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe [3]Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University [4]Department of Chemistry, University of Iowa

出　　处：《Neural Regeneration Research》2019年第3期437-440,共4页中国神经再生研究（英文版）

摘　　要：Neurodegenerative diseases such as Alzheimer's, Huntington's and Parkinson's diseases have multifaceted nature because of the different factors contributing to their progression. The complex nature of neurodegenerative diseases has developed a pressing need to design multitarget-directed ligands to address the complementary pathways involved in these diseases. The major enzyme targets for development of therapeutics for Alzheimer's disease are cholinesterase and β-secretase enzymes. In this review, we discuss recent advances in profiling single target inhibitors based on these enzymes to multitarget-directed ligands as potential therapeutics for this devastating disease. In addition, therapeutics based on iron chelation strategy are discussed as well.Neurodegenerative diseases such as Alzheimer's, Huntington's and Parkinson's diseases have multifaceted nature because of the different factors contributing to their progression. The complex nature of neurodegenerative diseases has developed a pressing need to design multitarget-directed ligands to address the complementary pathways involved in these diseases. The major enzyme targets for development of therapeutics for Alzheimer's disease are cholinesterase and β-secretase enzymes. In this review, we discuss recent advances in profiling single target inhibitors based on these enzymes to multitarget-directed ligands as potential therapeutics for this devastating disease. In addition, therapeutics based on iron chelation strategy are discussed as well.

关 键 词：multitarget-directed LIGANDS ACETYLCHOLINESTERASE Β-SECRETASE Alzheimer's disease HYBRIDIZATION NEURODEGENERATIVE diseases TACRINE brain permeability 

分 类 号：R[医药卫生]